Business Economy


Fertis India signs MoU to set up Rare Sugars Manufacturing Facility and Agri R&D Center in Telangana with Rs 2k cr investment

Hyderabad, Dec 9 (UNI) Fertis India Pvt. Ltd. on Tuesday signed a Memorandum of Understanding (MoU) with the Government of Telangana to establish a state-of-the-art Food & Agriculture Research and Development Center along with a Greenfield Rare Sugars Manufacturing Facility in the state.
The agreement was held in the presence of Chief minister A Revanth Reddy , during Day 2 of the Telangana Rising Global Summit, held at Bharat Future City here.
The proposed facility will focus on the production of allulose, glycine-based ingredients, slow-release carbohydrates, and other functional nutrients aimed at meeting the rising global demand for clean-label, non-GMO, and health-focused food ingredients, the company said.
According to the company, the project involves a total investment of ₹2,000 crore, to be executed in two phases — ₹500 crore in Phase 1 and ₹1,500 crore in Phase 2.
The project requires 100 acres of land and is expected to generate over 800 direct jobs in the next two years, the company said.
In addition, Fertis India has proposed another ₹200 crore project in Telangana focused onspecialty crop nutrition, bio-stimulants, and biological solutions aimed at promoting sustainable agriculture across the state.
UNI KNR ARN
More News

Stock market extends losing streak amid weak global cues

21 Jan 2026 | 7:11 PM

New Delhi, Jan 21 (UNI) Indian stock market extended its losing streak for a third consecutive session today amidst weaker global cues and the weakness of Indian rupee against US dollar, with the BSE Sensex crashing by 270.84 points or 0.33 percent to end negative at 81,909.63 and the Nifty s lipping by 75 points or 0.30 pc to 25,157.50.

see more..

21 Jan 2026 | 6:36 PM

Hyderabad, Jan 21 (UNI) Dr. Reddy’s Laboratories on Wednesday reported a 14 percent year-on-year decline in consolidated net profit for the third quarter ended December 31, 2025, as weaker sales of key drug Lenalidomide and pricing pressure in North America offset growth in India, Europe and emerging markets.

see more..

Wendt reports standalone sales of Rs 5,341 lakh, PAT Rs 579 lakh

21 Jan 2026 | 6:19 PM

Chennai, Jan 21 (UNI) Wendt (India) Limited, part of the Murugappa Group, today announced that said on a Standalone basis, it achieved sales of Rs. 5,341 lakh during the Quarter ended December 31 ‘25, which is 12% higher than the corresponding quarter previous year (YoY).

see more..

Pantomath Capital appoints Mitul Shah as MD for investment banking

21 Jan 2026 | 3:02 PM

Mumbai, Jan 21 (UNI) Pantomath Capital announced the appointment of Mitul Shah as Managing Director- Coverage and ECM Sales, Investment Banking.

see more..

Blaize signs MoU with Telangana for electronics, semiconductor, AI initiatives

21 Jan 2026 | 2:29 PM

Davos/Hyderabad, Jan 21 (UNI) The Chief Minister A Revanth Reddy-led ‘Telangana Rising’ delegation has signed a Memorandum of Understanding (MoU) with Blaize, a California-based company known for designing energy-efficient AI hardware and full-stack software for data-centre AI computing.

see more..